BRIEF published on 11/10/2026 at 10:05, 10 days 23 hours ago GENFIT divulgue le nombre total d'actions et de droits de vote en date d'octobre 2026 Droit De Vote Réglementation AMF Divulgation Du Capital Octobre 2026 Actions GENFIT
BRIEF published on 11/10/2026 at 10:05, 10 days 23 hours ago GENFIT Discloses Total Shares and Voting Rights as of October 2026 Voting Rights Capital Disclosure AMF Regulation October 2026 GENFIT Shares
PRESS RELEASE published on 11/10/2026 at 10:00, 10 days 23 hours ago Disclosure of the Total Number of Voting Rights and Shares Forming the Share Capital
BRIEF published on 11/09/2026 at 07:35, 12 days 2 hours ago GENFIT poursuit le développement de nangibotide dans l’ACLF avec des résultats prometteurs Phase 2 Inflammation GENFIT ACLF Nangibotide
BRIEF published on 11/09/2026 at 07:35, 12 days 2 hours ago GENFIT Unveils Clinical Insights on Nangibotide for ACLF Clinical Trials GENFIT ACLF Nangibotide TREM-1 Modulation
BRIEF published on 11/09/2026 at 07:35, 12 days 2 hours ago GENFIT dévoile des données cliniques sur le nangibotide dans le traitement de l'insuffisance hépatique aiguë sur cirrhose. Essais Cliniques GENFIT ACLF Nangibotide Modulation TREM-1
BRIEF published on 11/09/2026 at 07:35, 12 days 2 hours ago GENFIT continues the development of nangibotide in ACLF with promising results Phase 2 Inflammation GENFIT ACLF Nangibotide
PRESS RELEASE published on 11/09/2026 at 07:30, 12 days 2 hours ago GENFIT Highlights Data from Clinical Studies of Nangibotide, Supporting Its Advancement into ACLF with Phase 2 Data Expected in 2027
PRESS RELEASE published on 11/09/2026 at 07:30, 12 days 2 hours ago GENFIT présente les données issues des études cliniques de nangibotide soutenant la poursuite de son développement dans l’ACLF. Résultats de phase 2 attendus en 2027
BRIEF published on 11/02/2026 at 07:35, 19 days 2 hours ago GENFIT Highlights Advances in ACLF and MASH Diagnostics at AASLD 2026 Diagnostics GENFIT ACLF MASH Nangibotide
Published on 11/20/2026 at 15:00, 18 hours 50 minutes ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 19 hours ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 19 hours 50 minutes ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 20 hours 20 minutes ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 20 hours 20 minutes ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 10 hours 5 minutes ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 22:39, 11 hours 10 minutes ago ABIVAX: Abivax publie une déclaration concernant le rapport d'un vendeur à découvert
Published on 11/20/2026 at 21:36, 12 hours 14 minutes ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 20:49, 13 hours 1 minute ago E-PANGO: Jugement du Tribunal Judiciaire de Paris relatif au contentieux avec le groupement RIVP-HENEO-HSF
Published on 11/20/2026 at 18:34, 15 hours 15 minutes ago Déclaration hebdomadaire d'opérations effectuées du 16 au 20 novembre 2026
Published on 11/20/2026 at 18:34, 15 hours 15 minutes ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 16 hours 15 minutes ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 16 au 20 novembre 2026
Published on 11/20/2026 at 17:35, 16 hours 15 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 1 day 14 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR